User profiles for Jason K. Perry

Jason K Perry

Gilead Sciences
Verified email at gilead.com
Cited by 14824

Glide: a new approach for rapid, accurate docking and scoring. 1. Method and assessment of docking accuracy

…, EH Knoll, M Shelley, JK Perry… - Journal of medicinal …, 2004 - ACS Publications
Unlike other methods for docking ligands to the rigid 3D structure of a known protein receptor,
Glide approximates a complete systematic search of the conformational, orientational, and …

[HTML][HTML] Remdesivir is a direct-acting antiviral that inhibits RNA-dependent RNA polymerase from severe acute respiratory syndrome coronavirus 2 with high potency

…, EP Tchesnokov, E Woolner, JK Perry… - Journal of Biological …, 2020 - ASBMB
Effective treatments for coronavirus disease 2019 (COVID-19) are urgently needed to
control this current pandemic, caused by severe acute respiratory syndrome coronavirus 2 (SARS-…

Mutations in the SARS-CoV-2 RNA-dependent RNA polymerase confer resistance to remdesivir by distinct mechanisms

…, AS George, TM Hughes, X Lu, J Li, JK Perry… - Science translational …, 2022 - science.org
The nucleoside analog remdesivir (RDV) is a Food and Drug Administration–approved
antiviral for treatment of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[PDF][PDF] Remdesivir inhibits SARS-CoV-2 in human lung cells and chimeric SARS-CoV expressing the SARS-CoV-2 RNA polymerase in mice

…, K Gully, DR Martinez, AJ Brown, RL Graham, JK Perry… - Cell reports, 2020 - cell.com
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is the causative agent of
the novel viral disease COVID-19. With no approved therapies, this pandemic illustrates the …

Structural basis for RNA replication by the hepatitis C virus polymerase

TC Appleby, JK Perry, E Murakami, O Barauskas… - Science, 2015 - science.org
Nucleotide analog inhibitors have shown clinical success in the treatment of hepatitis C virus
(HCV) infection, despite an incomplete mechanistic understanding of NS5B, the viral RNA-…

[HTML][HTML] Template-dependent inhibition of coronavirus RNA-dependent RNA polymerase by remdesivir reveals a second mechanism of action

…, CJ Gordon, E Woolner, D Kocinkova, JK Perry… - Journal of Biological …, 2020 - ASBMB
Remdesivir (RDV) is a direct-acting antiviral agent that is used to treat patients with severe
coronavirus disease 2019 (COVID-19). RDV targets the viral RNA-dependent RNA …

[HTML][HTML] Ensemble cryo-EM reveals conformational states of the nsp13 helicase in the SARS-CoV-2 helicase replication–transcription complex

…, Y Pechersky, K Maruthi, ET Eng, JK Perry… - Nature structural & …, 2022 - nature.com
The SARS-CoV-2 nonstructural proteins coordinate genome replication and gene expression.
Structural analyses revealed the basis for coupling of the essential nsp13 helicase with …

Remdesivir and GS-441524 retain antiviral activity against Delta, Omicron, and other emergent SARS-CoV-2 variants

J Pitts, J Li, JK Perry, V Du Pont, N Riola… - Antimicrobial agents …, 2022 - Am Soc Microbiol
Genetic variation of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has
resulted in the emergence and rapid spread of multiple variants throughout the pandemic, of …

Antiferromagnetic band structure of  Becke-3–Lee-Yang-Parr calculations

JK Perry, J Tahir-Kheli, WA Goddard III - Physical Review B, 2001 - APS
Using the Becke-3–Lee-Yang-Parr (B3LYP) functional, we have performed band-structure
calculations on the high-temperature superconductor parent compound, La 2 CuO 4. Under …

Discovery of GS-9688 (Selgantolimod) as a potent and selective oral toll-like receptor 8 agonist for the treatment of chronic hepatitis B

RL Mackman, M Mish, G Chin, JK Perry… - Journal of Medicinal …, 2020 - ACS Publications
Toll-like receptor 8 (TLR8) recognizes pathogen-derived single-stranded RNA fragments to
trigger innate and adaptive immune responses. Chronic hepatitis B (CHB) is associated with …